Steven Paul

Company: Seaport Therapeutics (former CEO & CSO of Karuna Therapeutics)

Job title: Founder & Board Chair

Seminars:

The Evolution of Muscarinic Therapies : A New Era in Treating Schizophrenia and Other Neuropsychiatric Disorders 9:00 am

The discovery of anti-psychotic drugs The history and mode of action of xanomeline in early Alzheimer’s studies Exploring the potential efficacy of mAChR agonists for treating all three core symptom domains of schizophrenia, and in other indications, such as: dementiaassociated psychosis, Alzheimer’s disease , Parkinson’s psychosis , bipolar disorder and moreRead more

day: Day One